Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Overexpression of FGFR3 in HPV-positive Tonsillar and Base of Tongue Cancer Is Correlated to Outcome.

Bersani C, Haeggblom L, Ursu RG, Giusca SE, Marklund L, Ramqvist T, Näsman A, Dalianis T.

Anticancer Res. 2018 Aug;38(8):4683-4690. doi: 10.21873/anticanres.12774.

PMID:
30061236
2.

MicroRNA-155, -185 and -193b as biomarkers in human papillomavirus positive and negative tonsillar and base of tongue squamous cell carcinoma.

Bersani C, Mints M, Tertipis N, Haeggblom L, Näsman A, Romanitan M, Dalianis T, Ramqvist T.

Oral Oncol. 2018 Jul;82:8-16. doi: 10.1016/j.oraloncology.2018.04.021. Epub 2018 May 4.

PMID:
29909906
3.

Human papillomavirus (HPV) is absent in branchial cleft cysts of the neck distinguishing them from HPV positive cystic metastasis.

Sivars L, Landin D, Rizzo M, Haeggblom L, Bersani C, Munck-Wikland E, Näsman A, Dalianis T, Marklund L.

Acta Otolaryngol. 2018 Sep;138(9):855-858. doi: 10.1080/00016489.2018.1464207. Epub 2018 May 15.

PMID:
29764277
4.

Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome.

Ramqvist T, Näsman A, Franzén B, Bersani C, Alexeyenko A, Becker S, Haeggblom L, Kolev A, Dalianis T, Munck-Wikland E.

Int J Mol Sci. 2018 Mar 25;19(4). pii: E978. doi: 10.3390/ijms19040978.

5.

Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma.

Näsman A, Bersani C, Lindquist D, Du J, Ramqvist T, Dalianis T.

Anticancer Res. 2017 Oct;37(10):5319-5328. Review.

PMID:
28982840
6.

Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3.

Bersani C, Sivars L, Haeggblom L, DiLorenzo S, Mints M, Ährlund-Richter A, Tertipis N, Munck-Wikland E, Näsman A, Ramqvist T, Dalianis T.

Oncotarget. 2017 May 23;8(21):35339-35350. doi: 10.18632/oncotarget.15240.

7.

A model using concomitant markers for predicting outcome in human papillomavirus positive oropharyngeal cancer.

Bersani C, Mints M, Tertipis N, Haeggblom L, Sivars L, Ährlund-Richter A, Vlastos A, Smedberg C, Grün N, Munck-Wikland E, Näsman A, Ramqvist T, Dalianis T.

Oral Oncol. 2017 May;68:53-59. doi: 10.1016/j.oraloncology.2017.03.007. Epub 2017 Mar 23.

PMID:
28438294
8.

Effects of irradiation on human leukocyte antigen class I expression in human papillomavirus positive and negative base of tongue and mobile tongue squamous cell carcinoma cell lines.

Haeggblom L, Nordfors C, Tertipis N, Bersani C, Ramqvist T, Näsman A, Dalianis T.

Int J Oncol. 2017 Mar 16. doi: 10.3892/ijo.2017.3916. [Epub ahead of print]

PMID:
28350079
9.

Human papillomavirus is a favourable prognostic factor in cancer of unknown primary in the head and neck region and in hypopharyngeal cancer.

Sivars L, Bersani C, Grün N, Ramqvist T, Munck-Wikland E, Von Buchwald C, Dalianis T.

Mol Clin Oncol. 2016 Dec;5(6):671-674. doi: 10.3892/mco.2016.1050. Epub 2016 Oct 13.

10.

Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.

Sivars L, Landin D, Haeggblom L, Tertipis N, Grün N, Bersani C, Marklund L, Ghaderi M, Näsman A, Ramqvist T, Nordfors C, Munck-Wikland E, Tani E, Dalianis T.

Head Neck. 2017 Mar;39(3):419-426. doi: 10.1002/hed.24641. Epub 2016 Nov 29.

PMID:
27898186
11.

Genome-wide identification of Wig-1 mRNA targets by RIP-Seq analysis.

Bersani C, Huss M, Giacomello S, Xu LD, Bianchi J, Eriksson S, Jerhammar F, Alexeyenko A, Vilborg A, Lundeberg J, Lui WO, Wiman KG.

Oncotarget. 2016 Jan 12;7(2):1895-911. doi: 10.18632/oncotarget.6557.

12.

Human papillomavirus DNA and p16(INK4a) expression in hypopharyngeal cancer and in relation to clinical outcome, in Stockholm, Sweden.

Dalianis T, Grün N, Koch J, Vlastos A, Tertipis N, Nordfors C, Näsman A, Wendt M, Romanitan M, Bersani C, Munck-Wikland E, Ramqvist T.

Oral Oncol. 2015 Sep;51(9):857-61. doi: 10.1016/j.oraloncology.2015.06.002. Epub 2015 Jun 26.

PMID:
26120094
13.

The p53 target Wig-1 regulates p53 mRNA stability through an AU-rich element.

Vilborg A, Glahder JA, Wilhelm MT, Bersani C, Corcoran M, Mahmoudi S, Rosenstierne M, Grandér D, Farnebo M, Norrild B, Wiman KG.

Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15756-61. doi: 10.1073/pnas.0900862106. Epub 2009 Sep 1.

14.

PEG-metronidazole conjugates: synthesis, in vitro and in vivo properties.

Bersani C, Berna M, Pasut G, Veronese FM.

Farmaco. 2005 Sep;60(9):783-8.

PMID:
16040031

Supplemental Content

Loading ...
Support Center